PODD currently trades at 10x revenues compared ... Insulet has enjoyed lofty valuation multiples in the past due to its strong top and bottom-line growth. Our Insulet Valuation Ratios Comparison ...

Insulet (PODD) reported $597.5 million in revenue for ... Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what ...

Insulet (PODD) reported $432.7 million in revenue for ... As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps ...

Insulet (PODD) came out with quarterly earnings of ... Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow PODD in the coming trading sessions, be sure to utilize Zacks.com. Zacks Names ...

Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow PODD in the coming trading sessions, be sure to utilize Zacks.com. Zacks Names ...

I use the relative strength ratio shown in the bottom pane of Chart 1 to analyze the level of outperformance. The relative strength ratio rises when PODD outperforms the SP 500. The relative ...

↗️ Insulet (PODD): Surging revenue and the announcement of new share buybacks pushed the insulin pump maker's stock up by as much as 20%. ↘️ Expedia (EXPE): The online travel agency ...

Insulet (PODD) came out with quarterly earnings of ... In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 26% of the 250 plus Zacks industries.